John Cox, EVP Pharmaceutical Oper & Technology at BIOGEN INC. (BIIB), sold 12,010 shares at $449.06 ($5.4M) on 2015-03-25, disclosed to the SEC on 2015-03-26.
Scheduled sale ($5.4M) by EVP Pharmaceutical Oper & Technology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2026-06-17 | $49K | — | Filing → |
| DYN | SELL | 2026-05-14 | $61K | — | Filing → |
| DYN | SELL | 2026-03-06 | $41K | — | Filing → |